Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Cities for global health.

Ezzati M, Webster CJ, Doyle YG, Rashid S, Owusu G, Leung GM.

BMJ. 2018 Oct 3;363:k3794. doi: 10.1136/bmj.k3794. No abstract available.

2.

Comment on "The End of Phase 3 Clinical Trials in Biosimilars Development?"

Webster CJ, Woollett GR.

BioDrugs. 2018 Oct;32(5):519-521. doi: 10.1007/s40259-018-0297-y. No abstract available.

3.

Erratum to: A 'Global Reference' Comparator for Biosimilar Development.

Webster CJ, Woollett GR.

BioDrugs. 2017 Aug;31(4):287. doi: 10.1007/s40259-017-0236-3. No abstract available.

PMID:
28770499
4.

A 'Global Reference' Comparator for Biosimilar Development.

Webster CJ, Woollett GR.

BioDrugs. 2017 Aug;31(4):279-286. doi: 10.1007/s40259-017-0227-4. Erratum in: BioDrugs. 2017 Aug 2;:.

5.

Toward a Metagenomic Understanding on the Bacterial Composition and Resistome in Hong Kong Banknotes.

Heshiki Y, Dissanayake T, Zheng T, Kang K, Yueqiong N, Xu Z, Sarkar C, Woo PCY, Chow BKC, Baker D, Yan A, Webster CJ, Panagiotou G, Li J.

Front Microbiol. 2017 Apr 13;8:632. doi: 10.3389/fmicb.2017.00632. eCollection 2017.

6.
7.

A cost-effectiveness approach to the qualification and acceptance of biomarkers.

Williams SA, Slavin DE, Wagner JA, Webster CJ.

Nat Rev Drug Discov. 2006 Nov;5(11):897-902. Review.

PMID:
17080026
8.

Returning genetic research results to individuals: points-to-consider.

Renegar G, Webster CJ, Stuerzebecher S, Harty L, Ide SE, Balkite B, Rogalski-Salter TA, Cohen N, Spear BB, Barnes DM, Brazell C.

Bioethics. 2006 Feb;20(1):24-36. Review.

PMID:
16680905
9.

Genetic patent protection in the pharmaceutical and biotechnology industries.

Nunnally AC, Webster CJ, Brown SA, Cohen GA.

Community Genet. 2005;8(4):209-16.

PMID:
16244474
10.

Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.

Natarajan S, Jabbour JT, Webster CJ, Richardson MS.

Headache. 2004 Nov-Dec;44(10):969-77.

PMID:
15546259
11.

Prevalence of migraine in patients with a history of self-reported or physician-diagnosed "sinus" headache.

Schreiber CP, Hutchinson S, Webster CJ, Ames M, Richardson MS, Powers C.

Arch Intern Med. 2004 Sep 13;164(16):1769-72.

PMID:
15364670
12.

GW320659 for the treatment of attention-deficit/hyperactivity disorder in children.

DeVeaugh-Geiss J, Conners CK, Sarkis EH, Winner PK, Ginsberg LD, Hemphill JM, Laurenza A, Barrows CE, Webster CJ, Stotka CJ, Asgharnejad M.

J Am Acad Child Adolesc Psychiatry. 2002 Aug;41(8):914-20.

PMID:
12162627

Supplemental Content

Loading ...
Support Center